125 related articles for article (PubMed ID: 17685579)
1. Targeted proapoptotic anticancer drug delivery system.
Chandna P; Saad M; Wang Y; Ber E; Khandare J; Vetcher AA; Soldatenkov VA; Minko T
Mol Pharm; 2007; 4(5):668-78. PubMed ID: 17685579
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
5. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
[TBL] [Abstract][Full Text] [Related]
6. Novel polymeric prodrug with multivalent components for cancer therapy.
Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
Dharap SS; Qiu B; Williams GC; Sinko P; Stein S; Minko T
J Control Release; 2003 Aug; 91(1-2):61-73. PubMed ID: 12932638
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors.
Ying V; Haverstick K; Page RL; Saltzman WM
J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886
[TBL] [Abstract][Full Text] [Related]
10. Targeted proapoptotic LHRH-BH3 peptide.
Dharap SS; Minko T
Pharm Res; 2003 Jun; 20(6):889-96. PubMed ID: 12817893
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.
Dharap SS; Wang Y; Chandna P; Khandare JJ; Qiu B; Gunaseelan S; Sinko PJ; Stein S; Farmanfarmaian A; Minko T
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12962-7. PubMed ID: 16123131
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
13. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
15. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
18. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
Shen Y; Jin E; Zhang B; Murphy CJ; Sui M; Zhao J; Wang J; Tang J; Fan M; Van Kirk E; Murdoch WJ
J Am Chem Soc; 2010 Mar; 132(12):4259-65. PubMed ID: 20218672
[TBL] [Abstract][Full Text] [Related]
19. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
20. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
